Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus:arandomized controlled study

Diabetes Care

Volumn 40, Issue 3, 2017, Pages 332-337

  Nachum, Zohar ^a,b   Zafran, Noah ^a,b   Salim, Raed ^a,b   Hissin, Noura ^a   Hasanein, Jamal ^a   Ze Letova, Yifat Gam ^a   Suleiman, Abeer ^a   Yefet, Enav ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; INSULIN; METFORMIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; COMPARATIVE EFFECTIVENESS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MACROSOMIA; MAJOR CLINICAL STUDY; NEONATAL HYPOGLYCEMIA; PREGNANCY DIABETES MELLITUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; ADOLESCENT; COMBINATION DRUG THERAPY; DIABETES, GESTATIONAL; ISRAEL; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PREGNANCY; SAMPLE SIZE; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BLOOD GLUCOSE; DIABETES, GESTATIONAL; DRUG THERAPY, COMBINATION; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; ISRAEL; METFORMIN; MIDDLE AGED; PREGNANCY; PROSPECTIVE STUDIES; SAMPLE SIZE; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85019765853     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-2307     Document Type: Conference Paper

References (22)

1. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-1138
2. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358:2003-2015
3. Balsells M, Garćia-Patterson A, Sol á I, Roqúe M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: A systematic review and meta-Analysis. BMJ 2015;350:h102
4. Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic agents vs insulin in management of gestational diabetes: A systematic review and metaanalysis. Am J Obstet Gynecol 2010;203: 457.e1-457.e9
5. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007; 30(Suppl. 2):S251-S260
6. National Collaborating Centre for Womens and Childrens Health (UK). Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London, National Institute for Health and Care Excellence (UK), 2015
7. Committee on Practice Bulletins-Obstetrics. Practice bulletin no. 137: gestational diabetes mellitus. Obstet Gynecol 2013;122:406-416
8. Camelo Castillo W, Boggess K, Stürmer T, Brookhart MA, Benjamin DK Jr, Jonsson Funk M. Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. Obstet Gynecol 2014;123:1177-1184
9. Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol 2004;190:1438-1439
10. Silva JC, Pacheco C, Bizato J, de Souza BV, Ribeiro TE, Bertini AM. Metformin compared with glyburide for the management of gestational diabetes. Int J Gynaecol Obstet 2010;111:37-40
11. Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: A randomized controlled trial. Obstet Gynecol 2010;115:55-59
12. George A, Mathews JE, Sam D, et al. Comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamideda randomised controlled trial. Aust N Z J Obstet Gynaecol 2015;55:47-52
13. Camelo Castillo W, Boggess K, Stürmer T, Brookhart MA, Benjamin DK Jr, Jonsson Funk M. Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes. JAMA Pediatr 2015;169:452-458
14. Jiang YF, Chen XY, Ding T, Wang XF, Zhu ZN, Su SW. Comparative efficacy and safety of OADs in management of GDM: network meta-Analysis of randomized controlled trials. J Clin Endocrinol Metab 2015;100:2071-2080
15. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-773
16. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-1057
17. Ben-Haroush A, Yogev Y, Chen R, Rosenn B, Hod M, Langer O. The postprandial glucose profile in the diabetic pregnancy. Am J Obstet Gynecol 2004;191:576-581
18. Jacoby WG. Loess: A nonparametric, graphical tool for depicting relationships between variables. Elect Stud 2000;19:577-613
19. Poolsup N, Suksomboon N, Amin M. Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: A meta-Analysis. PLoS One 2014;9:e109985
20. Kimber-Trojnar Z, Marciniak B, Leszczy nska-Gorzelak B, Trojnar M, Oleszczuk J. Glyburide for the treatment of gestational diabetes mellitus. Pharmacol Rep 2008;60:308-318
21. Schwartz RA, Rosenn B, Aleksa K, Koren G. Glyburide transport across the human placenta. Obstet Gynecol 2015;125:583-588
22. Hebert MF, Ma X, Naraharisetti SB, et al.; Obstetric-Fetal Pharmacology Research Unit Network. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 2009;85:607-614